Cyclin E in breast tumors is cleaved into its low molecular weight forms by calpain

Oncogene

Volumn 22, Issue 5, 2003, Pages 769-774

  Wang, Xu Dong ^a,b   Rosales, Jesusa L ^a   Magliocco, Anthony ^a   Gnanakumar, Ruban ^a   Lee, Ki Young ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Calpain; Cyclin E

Indexed keywords

CALCIMYCIN; CALCIUM; CALPAIN; CYCLIN E; ELASTASE; PEPTIDE;

ARTICLE; BREAST TUMOR; CANCER TISSUE; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOPRECIPITATION; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; REGULATORY MECHANISM; TUMOR CELL;

BREAST NEOPLASMS; CALCIUM; CALPAIN; CYCLIN E; FEMALE; HUMANS; PRECIPITIN TESTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR CELLS, CULTURED;

EID: 0037421967     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206166     Document Type: Article

References (21)

1. Bradford MM. (1976). Anal. Biochem., 72, 248-254.
2. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA and Sutherland RL. (1993). Oncogene, 8, 2127-2133.
3. Croall DE and DeMartino GN. (1991). Physiol. Rev., 71, 813-847.
4. Dou QP, Pardee AB and Keyomarsi K. (1996). Nat. Med. 2, 254.
5. Ford HL, Kabingu EN, Bump EA, Mutter GL and Pardee AB. (1998). Proc. Natl. Acad. Sci. USA, 95, 12608-12613.
6. Harwell RM, Porter DC, Danes C and Keyomarsi K. (2000). Cancer Res., 60, 481-489.
7. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI and Weinberg RA. (1992). Cell, 70, 993-1006.
8. Kawasaki H and Kawashima S. (1996). Mol. Membr. Biol., 13, 217-224.
9. Keyomarsi K, Conte D, Toyofuku W and Fox MP. (1995). Oncogene, 11, 941-950.
10. Keyomarsi K and Herliczek TW. (1997). Prog. Cell Cycle Res., 3, 171-191.
11. Keyomarsi K and Pardee AB. (1993). Proc. Natl. Acad. Sci. USA, 90, 1112-1116.
12. Lee SW, Tomasetto C, Swisshelm K, Keyomarsi K and Sager R. (1992). Proc. Natl. Acad. Sci. USA, 89, 2504-2508.
13. Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P, Lowen D, Javni J, Miller FR, Slavin J and Anderson RL. (1999). Clin. Exp. Metastasis, 17, 163-170.
14. Nielsen NH, Arnerlov C, Emdin SO and Landberg G. (1996). Br. J. Cancer, 74, 874-880.
15. Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM and Pagano M. (1995). Mol. Cell. Biol., 15, 2612-2624.
16. Porter DC, Zhang N, Danes C, McGahren MJ, Harwell RM, Faruki S and Keyomarsi K. (2001). Mol. Cell Biol., 21, 6254-6269.
17. Said TK and Medina D. (1995). Carcinogenesis, 16, 823-830.
18. Saido TC, Sorimachi H and Suzuki K. (1994). FASEB J., 8, 814-822.
19. Sewing A, Ronicke V, Burger C, Funk M and Muller R. (1994). J. Cell Sci., 107, 581-588.
20. Shiba E, Kambayashi JI, Sakon M, Kawasaki T, Kobayashi T, Koyama H, Yayoi E, Takatsuka Y and Takai SI. (1996). Breast Cancer, 3, 13-17.
21. Steeg PS and Zhou Q. (1998). Breast Cancer Res. Treat., 52, 17-28.